Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Gastrointestinal Neoplasms × Sunitinib × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1 Available 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 12 Neoplasm Metastasis 5 Kidney Neoplasms 5 Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Glioblastoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Uveal Melanoma 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hormone Refractory Prostate Cancer 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Fatigue 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Carcinoid Tumor 1 Brain Neoplasms 1

Interventions

Drug Therapy 4 apatinib 3 Oxaliplatin 3 Irinotecan 3 pemigatinib 2 pembrolizumab 2 cemiplimab 2 avelumab 2 atezolizumab 2 S 1 (combination) 2 Nivolumab 2 Leucovorin 2 Folfox protocol 2 Fluorouracil 2 Everolimus 2 Erlotinib Hydrochloride 2 Endoscopic Mucosal Resection 2 Capecitabine 2 CGX1321 2 Bevacizumab 2 vandetanib 1 titanium silicide 1 tepotinib 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sodium thiosulfate 1 selpercatinib 1 pralsetinib 1 ponatinib 1 phosphatidyltransferase, Clostridium butyricum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡